Cargando…

Vernakalant and electrical cardioversion for AF – Safe and effective

AIMS: Rapid restoration of sinus rhythm is an integral part of the management of recent-onset atrial fibrillation. We aimed to assess safety and efficacy of vernakalant, a multi-channel blocking agent, in combination with external electrical cardioversion. METHODS: This prospective cohort study comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simon, Alexander, Niederdoeckl, Jan, Janata, Karin, Spiel, Alexander Oskar, Schuetz, Nikola, Schnaubelt, Sebastian, Herkner, Harald, Cacioppo, Filippo, Laggner, Anton Norbert, Domanovits, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626112/ https://www.ncbi.nlm.nih.gov/pubmed/31338415 http://dx.doi.org/10.1016/j.ijcha.2019.100398

Ejemplares similares

Body Weight Counts—Cardioversion with Vernakalant or Ibutilide at the Emergency Department
por: Lindmayr, Teresa, et al.
Publicado: (2022)

The Impact of the COVID-19 Pandemic on Incidences of Atrial Fibrillation and Electrical Cardioversion at a Tertiary Care Emergency Department: An Inter- and Intra-year Analysis
por: Schnaubelt, Sebastian, et al.
Publicado: (2020)

Cardioversion of Post-Ablation Atrial Tachyarrhythmia with Ibutilide and Amiodarone: A Registry-Based Cohort Study
por: Cacioppo, Filippo, et al.
Publicado: (2022)

Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department()
por: Simon, Alexander, et al.
Publicado: (2017)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Hyperkalemia: A persisting risk. A case report and update on current management
por: Schnaubelt, Sebastian, et al.
Publicado: (2020)

Association of Intravenous Potassium and Magnesium Administration With Spontaneous Conversion of Atrial Fibrillation and Atrial Flutter in the Emergency Department
por: Cacioppo, Filippo, et al.
Publicado: (2022)

Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation
por: Niederdöckl, Jan, et al.
Publicado: (2019)

Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study
por: Lévy, Samuel, et al.
Publicado: (2020)

Hemodynamic effects of Vernakalant in cardio-surgical ICU-patients treated for recent-onset postoperative atrial fibrillation
por: Schnaubelt, S., et al.
Publicado: (2020)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation in the Emergency Department: The SPECTRUM Study
por: Bager, Johan-Emil, et al.
Publicado: (2022)

Electrical cardioversion during pregnancy: safe or not?
por: Tromp, C. H. N., et al.
Publicado: (2011)

The ABC-Stroke Score Refines Stroke Risk Stratification in Patients With Atrial Fibrillation at the Emergency Department
por: Niederdöckl, Jan, et al.
Publicado: (2022)

Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation: A protocol for systematic review and meta-analysis
por: Li, Hong, et al.
Publicado: (2022)

High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction
por: Buchtele, Nina, et al.
Publicado: (2020)

Expert Opinion: Meditation and Cardiovascular Health: What is the Link?
por: Schnaubelt, Sebastian, et al.
Publicado: (2019)

Introducing Vernakalant into Clinical Practice
por: Hall, Angela JM, et al.
Publicado: (2019)

Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia–Pacific Region: A Phase 3 Randomized Controlled Trial
por: Beatch, Gregory N., et al.
Publicado: (2017)

Electrical cardioversion in healthy pregnant women: safe yes, but needed?
por: Crijns, H. J. G. M.
Publicado: (2011)

Electrical cardioversion
por: Sucu, Murat, et al.
Publicado: (2009)

Mechanism of blood-flow promotion during thoraco-abdominal compression-decompression CPR and standard CPR in man - preliminary results
por: Müllner, M, et al.
Publicado: (1997)

Impact of electric cardioversion on platelet activation
por: Haidl, Harald, et al.
Publicado: (2021)

External Electrical Cardioversion is an Easy and Safe Intervention for Rhythm Control in Persistent Atrial Fibrillation
por: Kwon, Chang Hee
Publicado: (2020)

Meta-analysis of effect of vernakalant on conversion of atrial fibrillation
por: Yan, He, et al.
Publicado: (2013)

Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis
por: Merino, Jose L, et al.
Publicado: (2019)

Which treatment for low back pain? A factorial randomised controlled trial comparing intravenous analgesics with oral analgesics in the emergency department and a centrally acting muscle relaxant with placebo over three days [ISRCTN09719705]
por: Havel, Christof, et al.
Publicado: (2001)

Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients
por: Rudiger, Alain, et al.
Publicado: (2014)

Electrical Cardioversion for Wide Complex Tachycardia
por: Roka, Abhishek, et al.
Publicado: (2019)

Electrical cardioversion for supraventricular arrhythmias in octagenarians
por: Malafaia, Felipe L., et al.
Publicado: (2019)

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers
por: Crijns, Harry JGM, et al.
Publicado: (2012)

Electrical cardioversion for early recurrences post pulmonary vein isolation
por: von Olshausen, Gesa, et al.
Publicado: (2022)

CPR in medical schools: learning by teaching BLS to sudden cardiac death survivors – a promising strategy for medical students?
por: Robak, Oliver, et al.
Publicado: (2006)

Standard blood laboratory values as a clinical support tool to distinguish between SARS-CoV-2 positive and negative patients
por: Thell, Rainer, et al.
Publicado: (2021)

Excess short-term mortality in noncritical patients with atrial fibrillation presenting to the emergency department
por: Niederdöckl, Jan, et al.
Publicado: (2021)

Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach
por: Schnaubelt, Sebastian, et al.
Publicado: (2021)

Effect of therapeutic mild hypothermia initiated by cold fluids after cardiac arrest on haemostasis as measured by thrombelastography
por: Spiel, A, et al.
Publicado: (2008)

Electric Cardioversion vs. Pharmacological with or without Electric Cardioversion for Stable New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Prasai, Paritosh, et al.
Publicado: (2023)

Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial
por: Lip, Gregory Y. H., et al.
Publicado: (2020)

Ultra-low-dose CT vs. chest X-ray in non-traumatic emergency department patients – a prospective randomised crossover cohort trial
por: Wassipaul, Christian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g0v50f6tjfokgmd9lgdeucbb1p